Alex Marson, MD, PhD is Director of the Gladstone-UCSF Institute of Genomic Immunology and Professor in the UCSF Department of Medicine, Division of Infectious Diseases. He serves as the scientific director for Human Health at the Innovative Genomics Institute and is a member of the Parker Institute for Cancer Immunotherapy. Dr. Marson’s work aims to understand the genetic programs controlling human immune cell function in health and disease, with an emphasis on developing and applying CRISPR genome engineering tools to primary immune cells, especially T cells. Combining genomics and gene editing approaches, the lab works to assess the consequences of coding and noncoding genetic variation on immune cell function and autoimmune disease risk and to genetically engineer human immune cells to target cancer, autoimmunity, and infectious diseases.

Dr. Marson completed medical school at Harvard, his PhD training at the Whitehead Institute/MIT with Richard Young and Rudolf Jaenisch, an Internal Medicine residency at the Brigham and Women’s and clinical training in Infectious Diseases at UCSF.